Sponsor study identifier
interventional
32
2 countries
2
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe primary aim of this study is to assess how effective PF-00592379 is in restoring penile erections in patients with erectile dysfunction. Patients will attend for 4 treatment visits where they will receive the following in random order; 2 separate doses of PF-00592379, sildenafil 100mg used as a positive control, or placebo (dummy medication). The effect on penile erections will be assessed in the clinic using penile plethysmography (RigiScan PlusTM technique).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
January 4, 2006
Actual (reported)January 9, 2006
Actual (reported)Duration of penile erections of greater than or equal to 60% rigidity as assessed by penile plethysmography (RigiScan PlusTM).
Duration and quality of penile erections recorded in a self-assessment diary.
Pfizer Investigational Site
Oslo, 0277, Norway
Pfizer Investigational Site
Belfast, Northern Ireland, BT9 6AD, United Kingdom
Pfizer CT.gov Call Center
Pfizer
First Submitted
January 4, 2006
First Posted
January 9, 2006
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
August 24, 2006
Record last verified: 2006-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
Contact the study team to confirm eligibility.